Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results

Go back to Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results

Biora Therapeutics, Inc. (BIOR) Tops Q3 EPS by 5c

November 14, 2022 4:05 PM EST

Biora Therapeutics, Inc. (NASDAQ: BIOR) reported Q3 EPS of ($0.03), $0.05 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $80 thousand versus the consensus estimate of $100 thousand.

For earnings history and earnings-related data on Biora Therapeutics, Inc. (BIOR) click here.

... More